LONZA recently announced that it has completed implementation of the next-generation Carniking process at its facility in Nansha, China.
L-carnitine improves the energy metabolism of animals, and Lonza, which supplies pharmaceutical, biotech and specialty ingredients, has developed its franchise for livestock and companion animals over the last few decades.
The innovative, next-generation process — developed by researchers in Lonza's Visp, Switzerland, site — allows production directly to the naturally occurring L-isomer. Using backward integration with raw materials produced in Visp, acetic acid becomes a precursor that is further processed to the molecule L-carnitine in the state-of-the-art Nansha site. There, it is formulated as Carniking, Carnifeed and Carnichrome for the feed industry.
This advanced, proprietary process allows Lonza to be independent of raw material suppliers and ensures quality and full traceability, an announcement said. The process has a low environmental impact for solid waste, salt, wastewater and organic waste from solvent recovery.
"The benefits for the customer of this proprietary Carniking process include the improved flowability and handling characteristics of the L-carnitine product itself," Lonza global marketing manager for Carniking Stephan Jacobs said. "Also, the new design ensures that reliable, cost-effective supplies are available without interruption. Our latest investment in this proven technology underscores our commitment to the feed business."
Carniking is patented in the U.S. and is patent pending in other countries.